Regional Account Manager
$186.5k - $234.8k+ Short- and long-term incentives
Senior
Bachelor's
United States
In Person
Sales & Account ManagementField Sales
About the job
Requirements
- A bachelor's degree is required; degrees in life sciences, business, or healthcare are preferred.
- A minimum of 5 years of pharmaceutical, biotech, or healthcare sales experience is required.
- A minimum of 3 years of rare disease, orphan drug, or highly specialized sales experience is required, including selling high-cost products distributed through specialty pharmacies and requiring extensive coordination with patient services.
- A proven track record of exceeding sales targets and successfully growing and managing a territory in prior roles is required.
- Previous selling experience in specialized clinics, hospitals, and academic centers, including the ability to perform complete account selling, is required.
- Demonstrated ability to analyze complex technical data and develop strategic and actionable business plans is required.
- Excellent verbal and written communication skills, including the ability to communicate complex technical information clearly, are required.
- Ability to work independently and collaboratively in a fast-paced, matrixed team environment with internal and external team members is required.
- Analytical thinking, problem-solving ability, and adaptability to changing priorities and deadlines are required.
- Excellent planning, organization, and time management skills, including the ability to support and prioritize multiple projects, are required.
- Proficiency with Microsoft Office is required.
- Ability to travel extensively throughout the assigned territory, including nights and weekends as needed, is required.
- A valid driver's license and personal automobile with active vehicle insurance are required. The employee must travel daily to and from customer accounts and drive long distances.
- The employee must comply with vendor credentialing requirements for daily entry to hospitals and other medical facilities, including required training, background checks, and proof of immunization.
- Candidates must reside near a major airport in one of the listed territories: the New England states, New York, Pennsylvania, West Virginia, Virginia, Maryland, North Carolina, South Carolina, or Georgia.
Responsibilities
- Represent PTC products to medical professionals specializing in diagnosing and treating neurological diseases and/or Fabry disease in the assigned region.
- Handle pharmaceutical sales and service operations, including generating sales, communicating and promoting product clinical and economic benefits, building and maintaining relationships, educating healthcare staff, and identifying commercial and scientific growth opportunities.
- Work cross-functionally with internal departments and external resources on sales-related issues.
- Support adherence to relevant regulatory requirements and company standard operating procedures.
- Achieve assigned sales targets compliantly and contribute to the metabolism business unit's success.
- Implement marketing strategies to meet monthly, quarterly, and yearly sales and patient objectives for neurology and/or Fabry disease products.
- Collaborate in a matrix environment with Patient Services, Patient Engagement, Marketing, Managed Markets, and Medical Affairs.
- Develop business partnerships with targeted physicians and healthcare staff, understand their needs, and discuss how PTC products and resources meet those needs.
- Identify key treatment centers and facilities, and collaborate across centers and with stakeholders to optimize patient care.
- Establish and maintain relationships with patient and disease-focused advocacy groups.
- Use a consultative, solution-oriented sales approach tailored to healthcare professionals treating patients with neurological diseases and/or Fabry disease.
- Address and resolve product access and reimbursement issues.
- Cultivate relationships with key thought leaders in the neurology and/or Fabry disease therapeutic area.
- Perform additional tasks and assignments as specified by management.
- Travel regularly within a multi-state territory, including overnight and weekend travel as needed, and travel outside the assigned territory for sales meetings, training programs, and other business activities.
Desired Qualifications
- Experience supporting orphan, rare disease, and/or specialized drugs is preferred.
- Experience working in a small, fast-growing, entrepreneurial sales environment is preferred.
- Experience in start-up environments and new product launches is preferred.
About the company
PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and markets medicines for rare genetic diseases. It uses RNA biology and post-transcriptional control to create therapies, including small-molecule drugs and gene therapies. Its products include Translarna for nmDMD, Evrysdi for SMA, Emflaza, Upstaza for AADC deficiency, and Kebilidi for CNS indications, all supported by an integrated model from research to commercialization and operations in more than 50 countries with a European base in Dublin. The company aims to provide safe, effective treatments to patients with few or no options by building a strong pipeline and broad global access.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Warren Township, New Jersey
Founded
1998
Get referred to PTC Therapeutics
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $361 million, and management raised 2026 guidance.
- Sephience data on September 25, 2026 reinforced diet liberalization and safety.
- PTC ended Q2 2026 with $2.23 billion cash after 0% notes refinancing.
What critics are saying
- Translarna lost EU authorization in March 2025; FDA withdrawal followed in February 2026.
- Sephience now powers the company; launch failure leaves PTC dependent on fading legacy assets.
- ST-920 faces bankruptcy-court, FDA, and accelerated-approval risk before Q4 2026 submission.
What makes PTC Therapeutics unique
- Sephience reached $151 million Q2 2026 revenue across 1,647 patients globally.
- PTC bought ST-920 on September 21, 2026, adding Fabry gene therapy commercialization.
- PTC's rare-disease commercial machine spans Evrysdi royalties, Sephience launches, and global distribution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- Flexible Work Hours
- Performance Bonus